On Thursday, U.S. Supreme Court Justice Clarence Thomas, along with his colleagues, unanimously upheld broad access to the abortion medication mifepristone, ensuring its availability for the time being. However, Justice Thomas took a unique position by writing separately to challenge a key standing rule. This standing rule, often paramount for litigants seeking to bring a case to court, has significant implications for access to judicial review in various legal contexts. For more detailed coverage, visit the full report published by Law360.